Respiratory Department, Ramón y Cajal Hospital, Ramón y Cajal Institute for Health Research (IRYCIS), Madrid 28034, Spain
Medicine Department, Alcalá University, Madrid, Spain.
BMJ. 2019 Jul 29;366:l4416. doi: 10.1136/bmj.l4416.
To evaluate the association between experience in the management of acute pulmonary embolism, reflected by hospital case volume, and mortality.
Multinational population based cohort study using data from the Registro Informatizado de la Enfermedad TromboEmbólica (RIETE) registry between 1 January 2001 and 31 August 2018.
353 hospitals in 16 countries.
39 257 consecutive patients with confirmed diagnosis of acute symptomatic pulmonary embolism.
Pulmonary embolism related mortality within 30 days after diagnosis of the condition.
Patients with acute symptomatic pulmonary embolism admitted to high volume hospitals (>40 pulmonary embolisms per year) had a higher burden of comorbidities. A significant inverse association was seen between annual hospital volume and pulmonary embolism related mortality. Admission to hospitals in the highest quarter (that is, >40 pulmonary embolisms per year) was associated with a 44% reduction in the adjusted odds of pulmonary embolism related mortality at 30 days compared with admission to hospitals in the lowest quarter (<15 pulmonary embolisms per year; adjusted risk 1.3% 2.3%; adjusted odds ratio 0.56 (95% confidence interval 0.33 to 0.95); P=0.03). Results were consistent in all sensitivity analyses. All cause mortality at 30 days was not significantly reduced between the two quarters (adjusted odds ratio 0.78 (0.50 to 1.22); P=0.28). Survivors showed little change in the odds of recurrent venous thromboembolism (odds ratio 0.76 (0.49 to 1.19)) or major bleeding (1.07 (0.77 to 1.47)) between the low and high volume hospitals.
In patients with acute symptomatic pulmonary embolism, admission to high volume hospitals was associated with significant reductions in adjusted pulmonary embolism related mortality at 30 days. These findings could have implications for management strategies.
评估以医院病例量反映的急性肺栓塞管理经验与死亡率之间的关联。
这是一项在 2001 年 1 月 1 日至 2018 年 8 月 31 日期间使用来自西班牙血栓栓塞登记处(RIETE 登记处)的数据进行的多国基于人群的队列研究。
16 个国家的 353 家医院。
39257 例确诊为急性有症状肺栓塞的连续患者。
诊断后 30 天内与肺栓塞相关的死亡率。
收入高容量医院(每年>40 例肺栓塞)的急性有症状肺栓塞患者合并症负担更高。医院每年的病例量与肺栓塞相关死亡率之间呈显著负相关。与收入低容量医院(每年<15 例肺栓塞)相比,收入高容量医院(每年>40 例肺栓塞)的患者,与肺栓塞相关的死亡率在 30 天内调整后的比值比降低了 44%(校正风险 1.3% 2.3%;调整后的比值比 0.56(95%置信区间 0.33 至 0.95);P=0.03)。所有敏感性分析结果均一致。在这两个季度之间,30 天的全因死亡率没有显著降低(调整后的比值比 0.78(0.50 至 1.22);P=0.28)。幸存者在低容量和高容量医院之间,复发性静脉血栓栓塞(比值比 0.76(0.49 至 1.19))或大出血(1.07(0.77 至 1.47))的复发几率几乎没有变化。
在急性有症状肺栓塞患者中,收入高容量医院与 30 天内调整后的肺栓塞相关死亡率显著降低相关。这些发现可能对管理策略有影响。